Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Manners-Holm L, Sthlman M, Olsson LM, Serino M, Planas-Flix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernndez-Real JM, Bckhed F
95% of children exposed by 9 months Neurodevelopmental disorder prevalence: 1960s: 1 in 10,000 1980s: 1 in 2,000 Late 1990s: 1 in 200 2021: 1 in 44 1996-2010: 269% increase in prevalence 1998-2018: 787% increase in UK The dramatic rise began in the late 1980s and accelerated through the 1990s and 2000sapproximately 25-30 years after acetaminophen's widespread adoption in pregnancy
MHY1485 treatment markedly reversed these effects (Figures S14G)
You might have fewer bowel movements, hard stools, or feel like you cannot fully empty your bowels
Reduced Intravenous Glutathione in the Treatment of Early Parkinsons Disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol
Eden differentiates with microdose options allowing patients to start at lower doses and titrate up gradually, which can reduce side effects and help patients who are hesitant about jumping straight to standard dosing